REGRANEX Pages on BioPortfolio:

Biotechnology News REGRANEX Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/REGRANEX-news.htm...

BioPortfolio - Regranex
Regranex - BioPortfolio - Indepth. ... SOMERVILLE, N.J., June 6 /PRNewswire/ -- ETHICON, INC. today announces revised labeling for REGRANEX Gel, ...
http://www.bioportfolio.com/indepth/Regranex.html...

BioPortfolio.com - BioWeb PROSTASCINT CAPROMAB PENDETIDE Search
... Inc Asparaginase Elspar Merck & Co., Inc Basiliximab Simulect Novartis Pharmaceuticals Corp Becaplermin Regranex OMJ Pharmaceuticals, Inc Becaplermin
...
http://www.bioportfolio.co.uk/PROSTASCINT+CAPROMAB+PENDETIDE...

BioPortfolio News: - Systagenix Announces Formation of New...
REGRANEX(R) (becaplermin) Gel 0.01% - a gel containing recombinant human platelet derived growth factor; the first and only growth factor approved for
...
http://www.bioportfolio.com/news/Systagenix-Announces-Format...

BioPortfolio Limited Worldwide Wound Management, 2007-2016 ...
3.10.2.4 Regranex 3.10.2.5 Other Growth Factors 3.10.2.6 Non-Growth Factor Modulators 3.10.3 Market and Competitive Analysis 3.10.3.1 Growth Factors ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_307.html...

BioPortfolio - Cardium Therapeutics - Cardium Announces Completion ...
protein [Regranex(R)] or negative pressure pumps, or "living-skin" equivalents). The MATRIX Data and Safety Monitoring Board has reviewed safety data ...
http://www.bioportfolio.com/news/Cardium_Announces_Completio...

BioPortfolio Limited Diabetes Market Forecast to 2013 (TA221)
Regranex * Lucentis * Atacand * Epicept NP-1 * Qnexa PRODUCT PROFILE COMPONENTS * Drug's development and approval history ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_742.html...

Results from other life science and pharmaceutical sites:

Warning for Regranex—Cream for Leg and Foot Ulcers
6 Jun 2008 ... A boxed warning has been added to the label of Regranex Gel 0.01% (becaplermin) to address the increased risk of cancer death in patients ...
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048471.ht...

Effect of recombinant platelet-derived growth factor (Regranex) on ...
Here, we sought to determine the effectiveness of commercially sold PDGF-BB ( Regranex) on wound closure in genetically diabetic mice. ...
http://www.ncbi.nlm.nih.gov/pubmed/16566566...

Communication about an Ongoing Safety Review of Regranex (becaplermin)
10 Jul 2009 ... In this study, among those who were prescribed Regranex three or more times, there was an increase in the number of patients who died as a ...
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInfo...

[Becaplermin gel (Regranex gel)]
Becaplermine gel (Regranex) is an hydrogel which contains 100 microg of Platelet Derived Growth Factor-BB (rhPDGF-BB) per gram. Regranex is presented in ...
http://www.ncbi.nlm.nih.gov/pubmed/15258509...

Regranex (becaplermin) Gel
27 Mar 2008 ... [UPDATE 06/06/2008] FDA informed healthcare professionals that a Boxed Warning was added to prescribing information for Regranex that ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...

Randomized clinical trial comparing OASIS Wound Matrix to Regranex ...
INTERVENTION: Patients were randomized to receive either OASIS Wound Matrix (n = 37) or Regranex Gel (n = 36) and a secondary dressing. ...
http://www.ncbi.nlm.nih.gov/pubmed/15942317...

FDA Announces New Labeling Changes for Regranex
6 Jun 2008 ... The US Food and Drug Administration today announced the addition of a boxed warning to the label of Regranex Gel 0.01% (becaplermin) to ...
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/20...

The cost-effectiveness of treating diabetic lower extremity ulcers ...
The cost-effectiveness of treating diabetic lower extremity ulcers with becaplermin (Regranex): a core model with an application using Swedish cost data
. ...
http://www.ncbi.nlm.nih.gov/pubmed/16464208...

Regranex (becaplermin) Gel 0.01 % October 2008
11 Jul 2009 ... An increased rate of mortality secondary to malignancy was observed in patients treated with 3 or more tubes of Regranex Gel in a ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...

ETHICON, INC. Announces Revised Label For REGRANEX® (becaplermin ...
6 Jun 2008 ... These data come from a retrospective study that compared cancer incidence and cancer mortality among 1622 patients exposed to REGRANEX Gel ...
http://www.jnj.com/connect/NewsArchive/all-news-archive/2008...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.